Compounds > 4-phenyl-3-furoxancarbonitrile

4-phenyl-3-furoxancarbonitrile and propranolol

4-phenyl-3-furoxancarbonitrile has been researched along with propranolol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arnér, ES; Austin, CP; Chakrapani, H; Inglese, J; Jadhav, A; Keefer, L; Lea, WA; Leister, W; Luecke, HF; Maloney, DJ; Prast-Nielsen, S; Rai, G; Sayed, AA; Shen, M; Simeonov, A; Thomas, CJ; Williams, DL	1

Other Studies

1 other study(ies) available for 4-phenyl-3-furoxancarbonitrile and propranolol

Article	Year
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis. Journal of medicinal chemistry, 2009, Oct-22, Volume: 52, Issue:20 Topics: Animals; Biological Availability; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Models, Molecular; Multienzyme Complexes; NADH, NADPH Oxidoreductases; Nitric Oxide; Oxadiazoles; Protein Conformation; Rats; Schistosoma; Schistosomiasis; Schistosomicides; Solubility; Structure-Activity Relationship; Substrate Specificity	2009

Article

Year

Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.

Journal of medicinal chemistry, 2009, Oct-22, Volume: 52, Issue:20

Topics: Animals; Biological Availability; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Models, Molecular; Multienzyme Complexes; NADH, NADPH Oxidoreductases; Nitric Oxide; Oxadiazoles; Protein Conformation; Rats; Schistosoma; Schistosomiasis; Schistosomicides; Solubility; Structure-Activity Relationship; Substrate Specificity

2009